Current studies into retatrutide peptide demonstrate significant possibility for treating weight and non-insulin dependent diabetes. The peptide, a dual stimulator of GLP-1 receptor and glucose-dependent insulinotropic polypeptide, looks to present improved weight reduction and glucose control in